首页 正文

A nomogram based on LASSO-logistic regression for predicting tocilizumab-associated hypofibrinogenemia in patients with rheumatic diseases

{{output}}
Introduction: Tocilizumab (TCZ), an IL-6 receptor inhibitor used in rheumatic diseases, can suppress fibrinogen synthesis and cause hypofibrinogenemia, yet its incidence, risk factors and predictive tools remain incompletely char... ...